Imunon Share Price

Imunon Share Price

NASDAQ: IMNN | Micro Cap | Healthcare
$0.57
-$0.04 (-5.89%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Imunon Stock Performance

Open
$0.63
Prev. Close
$0.61
Circuit Range
N/A
Day Range
$0.63 - $0.63
Year Range
$0.58 - $4.29
Volume
211
Average Traded
$0.63

Imunon Share Price Today

As of 19 November 2026, Imunon, Inc.'s share price is $0.57. The stock opened at $0.63, compared to its previous close of $0.61. During today's trading session, Imunon, Inc.'s share price traded between $0.63 and $0.63, with an average price of $0.63. Over the past 52 weeks, the stock has recorded a high of $4.29 and a low of $0.58. In terms of performance, Imunon, Inc.'s share price has declined by 73.67% over the last six months and is down 85.86% on a year-on-year basis.

Imunon Share Price Chart

Line chart of the Imunon price trend over the selected period. The price fell overall, ranging from 0.57 to 0.63, ending at 0.57.
$0.63$0.63
L
Show Current Price
H

Imunon Stock Fundamentals & Key Indicators

Market Cap
$1.22M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.32
Revenue (TTM)
$0.00
Return On Equity (TTM)
-574.08%
Profit Margin
N/A
Debt to Equity
2.38
Quarterly Earnings Growth YoY
11.14%

Imunon Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.22-$4.25-$2.83-$3.75
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-0.71%33.41%-32.51%

Imunon Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.50$0.00$0.00$0.00
Net Profit-$35.90-$19.51-$18.62-$14.50
Net Profit Margin-7180.00%N/AN/AN/A
Income ChangeN/A45.65%4.56%22.13%

Imunon Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.561.713.687.2
Current Assets10.728.0118.2436.78
Total Assets12.299.7221.9243.98
Non Current Liabilities0.60.691.144.61
Current Liabilities4.624.797.3910.04
Total Liabilities5.235.478.5314.65
Shareholders' Equity7.064.2413.3929.33

Imunon Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-13.9-18.85-19.02-23.1
Investing-0.289.8311.018.28
Financing17.099.06-3.646.72

Corporate Actions

Split
Ex-date: 07 Aug 2025

Split
Ex-date: 25 Jul 2025

Split
Ex-date: 01 Mar 2022

About Imunon

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Imunon Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.88
$0.63
-37.00%
Oct 2026
$1.27
$1.00
-24.24%
Sep 2026
$1.60
$1.32
-14.84%
Aug 2026
$1.57
$1.55
-2.52%
Jul 2026
$1.83
$1.59
-13.11%
Jun 2026
$2.25
$1.83
-16.06%
May 2026
$2.75
$2.18
-21.86%
Apr 2026
$2.90
$2.79
-3.79%
Mar 2026
$3.29
$2.90
-7.94%
Feb 2026
$3.25
$3.15
-5.26%
Jan 2026
$3.96
$3.33
-7.12%
Dec 2025
$4.04
$3.58
-11.80%

Imunon Share Price FAQs